Related Experiment Videos
Hippocampal electrical stimulation in mesial temporal lobe epilepsy
J F Tellez-Zenteno1, R S McLachlan, A Parrent
1Department of Clinical Neurological Sciences, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada.
Neurology
|March 24, 2006
Summary
Electrical stimulation of the hippocampus shows promising trends for reducing seizures in patients with drug-resistant mesial temporal lobe epilepsy (MTLE). While not statistically significant, this adjustable therapy demonstrated seizure reduction and no adverse effects in a small trial.
Area of Science:
- Neurology
- Neurosurgery
- Biomedical Engineering
Background:
- Pharmacoresistant epilepsy necessitates novel, adjustable, and reversible therapeutic strategies.
- Electrical stimulation of the hippocampus is a potential treatment for mesial temporal lobe epilepsy (MTLE).
Purpose of the Study:
- To evaluate the efficacy and safety of chronic hippocampal electrical stimulation in patients with refractory MTLE.
- To assess seizure reduction and other outcomes using a double-blind, randomized controlled design.
Main Methods:
- Four patients with refractory MTLE underwent implantation of a hippocampal depth electrode.
- A double-blind, randomized controlled crossover design was employed with alternating ON/OFF stimulation periods.
- Outcomes were assessed monthly using standardized instruments, accounting for washout periods.
Main Results:
- A median seizure reduction of 15% was observed with hippocampal stimulation.
- Seizure improvement occurred in all but one patient, though not reaching statistical significance.
- No significant differences in other outcomes were found, and no adverse effects were reported. Long-term benefits were noted in one patient.
Conclusions:
- Hippocampal electrical stimulation shows beneficial trends and long-term seizure improvement in MTLE patients without adverse effects.
- Observed effect sizes were smaller than those in previous non-randomized, unblinded studies.
- Further research is warranted to confirm the efficacy of this therapeutic approach.